X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
rna interference (2) 2
animals (1) 1
biomarker (1) 1
biomarkers, tumor (1) 1
brivaracetam (1) 1
care and treatment (1) 1
cell line (1) 1
cell movement - genetics (1) 1
choline (1) 1
depression (1) 1
depression, mental (1) 1
dosage and administration (1) 1
double-blind (1) 1
down-regulation (1) 1
epilepsy (1) 1
gene expression regulation, neoplastic (1) 1
gene knockdown techniques (1) 1
genes (1) 1
genotype & phenotype (1) 1
humans (1) 1
index medicus (1) 1
levetiracetam (1) 1
ligands (1) 1
male (1) 1
medicine, general & internal (1) 1
mental depression (1) 1
mice (1) 1
mrs (1) 1
ontology (1) 1
patients (1) 1
phospholipase c gamma - genetics (1) 1
phospholipase c gamma - metabolism (1) 1
phosphorylcholine - metabolism (1) 1
plcγ1 (1) 1
prostatic neoplasms - metabolism (1) 1
prostatic neoplasms - pathology (1) 1
risk factors (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Neurology, Neurosurgery & Psychiatry, ISSN 0022-3050, 10/2018, Volume 89, Issue 10, pp. A32 - A33
BackgroundInherited neuropathies are genetic conditions affecting the peripheral motor and sensory nerves. The number of causative genes are continuing to... 
Ontology | Genotype & phenotype | Genes
Journal Article
Journal of Neurology, Neurosurgery & Psychiatry, ISSN 0022-3050, 12/2016, Volume 87, Issue 12, pp. e1 - e1
BackgroundMyasthenia Gravis (MG) is an autoimmune disorder presenting with fatigable muscle weakness leading to potential respiratory distress. Clinical... 
Journal Article
Postgraduate Medical Journal, ISSN 0032-5473, 09/2017, Volume 93, Issue 1103, pp. 566 - 566
Treatment with levetiracetam was associated with a seven-fold increase in the risk of depression. 2 Nonetheless, rapid loading, easy conversion from oral to... 
DOUBLE-BLIND | MEDICINE, GENERAL & INTERNAL | Depression | Brivaracetam | Epilepsy | Levetiracetam | Care and treatment | Dosage and administration | Depression, Mental | Risk factors | Ligands | Mental depression | Patients
Journal Article
Molecular Cancer Therapeutics, ISSN 1535-7163, 05/2009, Volume 8, Issue 5, pp. 1305 - 1311
Phosphoinositide-specific phospholipase Cγ1 (PLCγ1) is activated downstream of many receptor tyrosine kinases to promote cell motility. Inhibition of this... 
choline | RNA interference | biomarker | PLCγ1 | MRS
Journal Article
Molecular cancer therapeutics, ISSN 1535-7163, 05/2009, Volume 8, Issue 5, pp. 1305 - 1311
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.